###begin article-title 0
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
Somatic frameshift mutations in the Bloom syndrome BLM gene are frequent in sporadic gastric carcinomas with microsatellite mutator phenotype
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
Genomic instability has been reported at microsatellite tracts in few coding sequences. We have shown that the Bloom syndrome BLM gene may be a target of microsatelliteinstability (MSI) in a short poly-adenine repeat located in its coding region. To further characterize the involvement of BLM in tumorigenesis, we have investigated mutations in nine genes containing coding microsatellites in microsatellite mutator phenotype (MMP) positive and negative gastric carcinomas (GCs).
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 126 177 126 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII, IGFIIR, hMSH3, hMSH6, BAX, WRN, RECQL</italic>
###xml 182 185 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
We analyzed 50 gastric carcinomas (GCs) for mutations in the BLM poly(A) tract aswell as in the coding microsatellites of the TGFbeta1-RII, IGFIIR, hMSH3, hMSH6, BAX, WRN, RECQL and CBL genes.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 205 217 205 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 226 229 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 237 242 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 249 254 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 262 265 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 273 279 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR</italic>
###xml 286 291 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RECQL</italic>
###xml 301 304 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 324 327 321 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 388 391 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 399 404 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 411 417 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3.</italic>
###xml 430 433 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 593 596 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
BLM mutations were found in 27% of MMP+ GCs (4/15 cases) but not in any of the MMP negative GCs (0/35 cases). The frequency of mutations in the other eight coding regions microsatellite was the following: TGFbeta1-RII (60 %), BAX (27%), hMSH6 (20%),hMSH3 (13%), CBL (13%), IGFIIR (7%), RECQL (0%) and WRN (0%). Mutations in BLM appear to be more frequently associated with frameshifts in BAX and in hMSH6and/or hMSH3. Tumors with BLM alterations present a higher frequency of unstable mono- and trinucleotide repeats located in coding regions as compared with mutator phenotype tumors without BLM frameshifts.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
BLM frameshifts are frequent alterations in GCs specifically associated with MMP+tumors. We suggest that BLM loss of function by MSI may increase the genetic instability of a pre-existent unstable genotype in gastric tumors.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 872 873 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 890 914 890 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH2, hMLH1, PMS1, PMS2</italic>
###xml 919 929 919 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6/GTBP</italic>
###xml 930 931 930 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1264 1265 1264 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1266 1268 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1429 1434 1429 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMLH1</italic>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 211 216 <span type="species:ncbi:9606">human</span>
###xml 579 584 <span type="species:ncbi:9606">human</span>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
Cancer is a progressive genetic disease characterized by progressive accumulation of mutations in both coding and non-coding sequences [1]. Simple sequence repeats or microsatellites are highly unstable in some human neoplasms, identifying a class of tumors with the microsatellite mutator phenotype (MMP+) (for review see [2]). MMP+ve status is defined by instability in more than 30% of analised microsatellites, including at least one mononucleotide (such as BAT26 or BAT25) [3]. Microsatellite instability (MSI) has been described as a frequent genetic alteration in various human solid tumors including sporadic and familial gastric carcinomas (GCs). In almost all patients with hereditary nonpolyposis colorectal cancer (HNPCC), molecular studies have shown that MSI is caused by germline mutations in genes encoding proteins required for DNA mismatch repair (MMR) [4]. Genes such as hMSH2, hMLH1, PMS1, PMS2 and hMSH6/GTBP[5-8], were defined as "caretakers" because, when disrupted, they favor the acquisition of mutations at high frequency in several genes including oncogenes and tumor suppressor genes [9]. However, in a significant fraction of sporadic MMP+ tumors, mutation analysis has not allowed the identification of the genes responsible for MSI [2,10], suggesting that, in such cases, MSI might be caused by epigenetic mechanisms. In fact, gene silencing by promoter hypermethylation was recently shown for the hMLH1 gene [11-13].
###end p 10
###begin p 11
###xml 382 394 382 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 446 452 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR</italic>
###xml 485 490 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 495 501 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6,</italic>
###xml 524 527 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 557 562 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-4</italic>
###xml 563 565 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 566 568 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 615 621 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2F-4,</italic>
###xml 1005 1007 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1198 1200 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1201 1203 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1206 1209 1194 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 1254 1257 1242 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 1300 1302 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1321 1326 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 1331 1336 1319 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 1369 1373 1357 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MutS</italic>
###xml 1476 1478 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1515 1520 1503 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 1589 1590 1577 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
The significance of MSI in tumorigenesis has been supported by the demonstration that the genetic instability characterizing MMP+ gastrointestinal cancers may target short repetitive tracts within the coding region of genes important for cell survival and proliferation. Insertion/deletion mutations were found in the genes for the transforming growth factor-beta type II receptor (TGFbeta1-RII), the insulin-like growth factor type II receptor (IGFIIR), the DNA mismatch-repair genes hMSH3 and hMSH6, the proapoptotic gene BAX and the transcription factor E2F-4[14-18]. In all the cases, with the exception of the E2F-4, the nucleotides insertion/deletion resulted in frameshift mutations and protein truncation. Although the biological significance of these alterations is not fully established, it was proposed that the absence of TGFbeta1-RII receptors from the surface of gastrointestinal epithelial cells could eliminate the negative growth control of TGF-beta, leading to uncontrolled cell growth [19]. IGFIIR has a role in growth suppression by binding and activating the TGFbeta1 receptor complex and by mediating internalization, with subsequent degradation, of the growth factor IGF-II [20,21]. BAX promotes apoptosis and it was reported that BAX inactivation leads to rapid tumor growth [22]. The human genes hMSH3 and hMSH6 are homologous to the bacterial MutS gene whose products bind DNA mismatches to initiate strand-specific repair of DNA replication errors [23]. Somatic and germline mutations in hMSH6 were associated with sporadic MMP+ colorectal carcinomas and HNPCC [6].
###end p 11
###begin p 12
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 716 719 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
We have found previously that the BLM gene may also be a target of MSI [24]. The frameshifts, found in a short poly-adenine repeat, were predicted to generate a truncated and non-functional BLM protein. Homozygous or compound heterozygous mutations at the BLM gene were shown to cause the Bloom syndrome (BS; OMIM 210900), a pre-malignant condition characterized by chromosomal instability and increased mutational rate. BS patients are predisposed to a wide variety of neoplams diagnosed at early age. Noteworthy, among 100 neoplasms recorded in the BS registry, 19 were gastrointestinal (esophagus, stomach and colon) and only two were diagnosed after the age of 40 [25]. These data indicate that mutations in the BLM gene can promote tumorigenesis.
###end p 12
###begin p 13
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
To better define the role of BLM in gastrointestinal tumorigenesis we screened a panel of MMP+ and MMP- gastric carcinomas (GCs) for: a) frameshifts in the BLM coding region microsatellite and b) for possible associations with other intragenic frameshifts.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
MSI status
###end title 15
###begin p 16
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 959 962 959 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 991 992 991 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
For the present study, our panel of 50 GCs contains 15 MMP+ tumors with MSI at two or more loci (Table 2) and 35 GCs MMP- with alteration at one microsatellite (4 tumors) or without MSI (31 tumors). All the MMP+ cases were BAT 26 positive, and BAT 25 instability was found in 13 out of 15 cases (except cases 67R and 27P). The clinico-pathological features of MMP+ tumors are described in Table 1. The MMP+ phenotype was closely associated with a low pTNM stage and with a less prevalent nodal metastases (p = 0.02 and p = 0.001 at Fisher exact test, respectively, vs. MMP-tumors). Within the MMP+ group, an excess of tumors in early stages and without lymph node metastasis was found (10/15 cases vs. 10/32 cases of MMP- cases, p = 0.02 and 11/15 cases vs. 7/32 cases of MMP- cases, p = 0.001, respectively), data that support the proposed better prognostic of GCs MMP+ [33,34]. Of note, no excess of intestinal type among MMP+ tumors was found (12/15 cases vs. 20/32 of MMP- cases) (Table 1), data in accordance with recent studies showing no significant difference in the frequency of MSI in intestinal-type and diffuse-type carcinomas [26,35].
###end p 16
###begin p 17
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
Histotype and staging parameters associated with the MMP phenotype in our GCsa
###end p 17
###begin p 18
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
a - data were available for 47 out of 50 cases b - at Fisher exact test c - NS = not statistically significant
###end p 18
###begin p 19
###xml 44 97 44 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM, WRN, RECQL, CBL, hMSH6, hMSH3,IGFIIR,TGF-&#946;RII</italic>
###xml 102 105 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
Status of the coding microsatellites within BLM, WRN, RECQL, CBL, hMSH6, hMSH3,IGFIIR,TGF-betaRII and BAX genes in the series of gastric carcinomas with microsatellite mutator phenotype.
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
a - I = intestinal type; D = diffuse type; M = mixed type b - according to the TNM classification (Sobin and Wittekind, 1997) c - number of unstable / total tested microsatellites d - data compiled from the references: [17,27,42,50,51,52]
###end p 20
###begin title 21
BLM frameshifts
###end title 21
###begin p 22
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 675 678 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 912 946 912 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII, IGFIIR, hMSH3, hMSH6</italic>
###xml 951 954 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 962 964 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 965 967 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 968 970 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 971 973 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
PCR amplification of the BLM microsatellite revealed abnormal bands, absent in the normal matched DNAs, in 4 of the 15 MMP+ tumors (27%) (Fig. 1). We have confirmed by sequencing that the abnormal bands are caused by a deletion of one adenine residue in the poly-adenine tract (reduction from nine to eight adenines), as previously shown [24]. The mutation frequency in BLM may be a low estimate, because we have excluded cases in which abnormal bands in tumor DNAs were notably weaker than the normal ones, possibly in consequence of a large contamination of tumor with nonmalignant cells or of a low portion of malignant cells displaying the abnormality (Fig. 1). Since no BLM mutation was seen in MMP- tumors, frameshift mutations in the BLM gene appear to be specifically associated with gastric MMP+ tumors (probability P < 0.01 at Fisher exact test), similar to the previous well-documented alterations in TGFbeta1-RII, IGFIIR, hMSH3, hMSH6 and BAX genes [14,16,17,32]. Therefore, our data expand the repertoire of altered genes associated with MMP+ gastric carcinomas.
###end p 22
###begin p 23
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 703 706 703 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Representative examples of mutations detected in microsatellites at gene coding regions. Case numbers are shown above each matching normal (N) and tumor (T) DNA pairs. Arrows indicate the abnormal bands. Note that we have not considered mutated samples where abnormal bands were very faint (like in the BLM and BAX genes of tumor sample 30P). Because of the tendency of Taq polymerase to add an extra nucleotide at the end of the synthesized DNA fragments, PCR products appear sometimes as double bands. With the exception of BAX frameshift in tumor 69R, no other mutation appears to be homozygous. However, by knowing the ratio of malignant cells in tumor sample, we have previously indicated that the BLM mutation in tumor 69R is also homozygous [24].
###end p 23
###begin title 24
Frameshifts in other CDRs microsatellites and relations with BLM frameshifts
###end title 24
###begin p 25
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 207 241 207 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII, IGFIIR, hMSH3, hMSH6</italic>
###xml 246 249 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 323 335 320 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 372 373 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 423 425 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 552 559 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR,</italic>
###xml 618 619 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 656 659 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 676 688 670 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 752 755 743 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 839 842 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 930 933 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 951 954 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 959 964 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 972 977 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 998 999 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
The same panel of MMP+ tumors was also analyzed for the presence of frameshifts in microsatellites located in the coding regions of eight other genes (Table 2). We have found variation in sequence length in TGFbeta1-RII, IGFIIR, hMSH3, hMSH6 and BAX genes, all previously reported to be altered in MMP+ GCs. Data about the TGFbeta1-RII status for eight (P series in Table 2) of the fifteen tumors were previously reported [27]. The observed mutation frequencies were comparable with those previously reported for all these genes, with the exception of IGFIIR, for which we found a low percentage of frameshifts (Table 2). Interestingly, in comparison with BLM mutations, only TGFbeta1-RII frameshifts were more frequent (60% vs. 27%, respectively) and BAX frameshifts were as well as frequent (27%). These data suggest that frameshifts in BLM are common alterations in MMP+ GCs. A trend toward an association between mutations in BLM and mutations in BAX and hMSH3 and/or hMSH6 was observed (Table 2) (P = 0,05 at Fisher exact test).
###end p 25
###begin p 26
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQL, WRN</italic>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQL</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 755 758 755 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 948 951 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 971 972 971 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1127 1130 1127 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1161 1162 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1176 1177 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 224 229 <span type="species:ncbi:9606">human</span>
We have also analyzed the RecQL, WRN and CBL genes, which contain short repeats in their coding regions. The first two genes are members of the same helicase gene family as BLM[36,37]. While RecQL is not associated with any human disease, mutations in the WRN gene are cause of the Werner syndrome (WS; OMIM 277700), a rare autosomal recessive disorder clinically characterized by premature aging and increased risk for a variety of neoplasms, and genetically characterized by genomic instability. CBL is a tyrosine kinase receptor [38], whose deregulation was associated with oncogenesis [39]. We have found mutations only in the CBL gene (Fig. 1). Two samples (69R and 14P) were found to carry a 3 bp insertion in the trinucleotide (ATG)6 repeat of the CBL gene (data not shown). As we have previously reported [24], since no frameshift is produced, no functional consequence can be inferred. Both mutations were found in cancers displaying also BLM frameshifts (Table 2). It is noteworthy that this subset of tumors show a statistically significant excess of MSI in coding regions when compared with the MMP+ subset without BLM alterations (P < 0.001, at Chi2 test) (Table 2).
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 524 536 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 541 545 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX.</italic>
###xml 574 579 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 584 589 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 666 672 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR</italic>
###xml 673 675 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 719 731 716 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII</italic>
###xml 762 768 756 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR</italic>
###xml 947 949 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1003 1004 997 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1007 1010 1001 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1192 1197 1186 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 1205 1210 1199 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 1288 1291 1282 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 1346 1350 1340 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM,</italic>
###xml 1386 1394 1380 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX (see</italic>
###xml 1402 1403 1396 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1405 1412 1399 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and p53</italic>
###xml 1473 1476 1467 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1506 1511 1500 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3</italic>
###xml 1519 1524 1513 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
Several studies have documented that alternative pathways may exist in gastrointestinal MMP+ and MMP- cancers characterized by different sets of altered genes [40]. A gradual model of mutator mutations ("the mutator that mutates the other mutator") was proposed to define the mutator versus the suppressor pathways in gastrointestinal tumors [41]. By analyzing the timing of mutational events in genetically unstable GCs, it was proposed that the first targets of mismatch repair deficiency are the mononucleotide tracts of TGFbeta1-RII and BAX. The frameshift mutations of hMSH3 and hMSH6 appear to be secondary mismatch repair lesions, which generate mutations in IGFIIR[42]. The finding that frameshift mutations at TGFbeta1-RII are the most frequent and the IGFIIR are the less frequent in gastric MMP+ tumors supports to the model in which early events should be present in the majority of tumors and late mutations only in a minor fraction [43]. This finding is also confirmed in our study (Table 2). BLM frameshift mutations are associated more frequently with first and second step alterations proposed in this model, suggesting that they are secondary to mismatch repair defects (in hMSH3 and/or hMSH6) present in cells which do not undergo apoptosis (possibly in consequence of BAX inactivation). Noteworthy, in case 3P, in addition to BLM, the only frameshifts were found in BAX (see figure 1) and p53 (data not shown) genes, suggesting that, in some instances, BLM alteration may occur without hMSH3 and/or hMSH6 mutations, in cells with abnormal p53-mediated pathway of apoptotic response to DNA mismatch.
###end p 28
###begin p 29
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1075 1083 1075 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM gene</italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">radl2</italic>
###xml 1100 1101 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1102 1106 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rqhl</italic>
###xml 1106 1107 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1264 1267 1264 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1314 1317 1314 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1470 1473 1470 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1688 1690 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1691 1693 1691 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1765 1768 1765 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1878 1880 1878 1880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1924 1928 1924 1928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SGS1</italic>
###xml 1939 1963 1939 1963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 1977 1980 1977 1980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 1985 1989 1985 1989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN,</italic>
###xml 2214 2216 2214 2216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 1061 1074 <span type="species:ncbi:4896">fission yeast</span>
###xml 1939 1963 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The involvement of BLM in tumorigenesis outside BS patients seems conceivable, since this gene appears to act as a caretaker. BLM mutations are known to cause an increased genomic instability characterized by an elevated number of chromosomal breaks, gaps and rearrangements and by an excessive number of mutations in both coding and noncoding regions, likely originated by unequal sister-chromatid exchange, characteristic feature of the Bloom syndrome [44,45]. Accordingly, BS exhibits a combination of genomic instability and elevated cancer risk, an association found also in other diseases caused by defects in caretaker genes (such as HNPCC, WS, ataxia-telangiectasia and xeroderma pigmentosum). Similar to the mutations found in BS, the frameshifts described in GCs abolish the helicase function of the BLM protein [24]. BLM protein has a proven DNA unwinding activity [46] and could be involved in processes that are disturbed in malignant cells, such as DNA replication, recombination, chromosome segregation, DNA repair and transcription. Indeed, the fission yeast BLM gene homologue (radl2+/rqhl+) was shown to regulate the S-phase checkpoint and was proposed to couple chromosomal integrity with cell cycle progression [47,48]. However, the finding of BLM mutations in MMP+ tumors generates a paradox: BLM mutations are predicted to generate chromosomal instability while most of the MMP+ tumors are diploid. Nevertheless, some MMP+ tumors are aneuploid and BLM loss-of-function mutations may have pleiotropic consequences, possibly affecting also the microsatellite instability pathway, as suggested by the description of an increased intra-gene mutations in Bloom syndrome [44,45]. In suppoprt to our suggestion is the finding that we have found that BLM is mutated in LoVo cell line, a colon cancer cell line with both microsatellite and chromosomal inatability [43]. Much more, it was recently reported that SGS1 gene, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination and is redundant with DNA mismatch repair (MMR) for suppressing gross chromosomal rearrangements and for suppressing recombination between divergent DNA sequences [49].
###end p 29
###begin title 30
Conclusions
###end title 30
###begin p 31
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6</italic>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3,</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 456 459 456 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
Our results indicate that BLM frameshifts are frequent alterations in GCs and are specifically associated with MMP+ tumors displaying at least 2 unstable microsatellites. Mutations in BLM appear to be frequently associated with frameshifts in BAX and in hMSH6 and/or hMSH3, and tumors with BLM alterations present a number of unstable mono- and trinucleotide repeats located in coding regions significantly higher than that observed in MMP+ tumors without BLM frameshifts. We suggest that BLM loss of function by MSI in gastric tumors is an intermediate mutational event, which may increase the instability of a pre-existent unstable genotype.
###end p 31
###begin title 32
Methods
###end title 32
###begin title 33
Tumor Samples
###end title 33
###begin p 34
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
Fifty primary gastric tumors and their normal paired tissues (blood or normal gastric mucosa) were selected on the basis of available DNA from a panel of 80 gastric tumors (27, Calin G and Negrini M unpublished data). When possible, areas of tumor tissue with minimal inflammatory cells or minimal stroma, or both, were selected to obtain a neoplastic cell load greater than 50%. All cases were identified histopathologically as adenocarcinomas. Histotype (according to Lauren's classification) [28] and staging (according to the TNM classification) [29] was known for 47 out of 50 cases (94%) (Table 1). Thirty-two cases were of intestinal histotype and 15 cases of diffuse or mixed type. Twenty tumors were staged I or II, while 27 were in stage III or IV. Regarding the lymph node status, eighteen cases were NO and 29 were N-positive. None of the patients had developed a cancer at an early age, and none had a family history suggestive of genetic predisposition to cancer. High molecular weight DNAs was isolated using established procedures [30].
###end p 34
###begin title 35
Assessment of MSI
###end title 35
###begin p 36
###xml 65 92 65 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11S1778, D11S1328, D11S922</italic>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11S1318</italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 118 159 118 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D2S177, D3S1076, D5S433, D11S904, D17S796</italic>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D18S59</italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAT25</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAT26</italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
MSI was revealed with two sets of anonymous markers at loci: (i) D11S1778, D11S1328, D11S922 and D11S1318[24] or (ii) D2S177, D3S1076, D5S433, D11S904, D17S796 and D18S59[27]. The primers for these dinucleotide microsatellite loci were obtained from information available through the Genome DataBase. PCR amplifications were carried out as previously described [24,27]. For all samples the BAT25 and BAT26 microsatellites were analyzed by PCR amplification as described [31]. MSI was assessed if a mobility shift of PCR products from tumor DNA compared with the normal counterpart was identified. Only tumors with at least 2 MSI (>30% of tested microsatellites) were considered MMP+.
###end p 36
###begin title 37
Amplification of microsatellites in BLM and in other coding regions (CDRs)
###end title 37
###begin p 38
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 815 828 782 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1-RII,</italic>
###xml 841 848 805 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFIIR,</italic>
###xml 861 865 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX,</italic>
###xml 878 884 842 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH3,</italic>
###xml 897 903 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH6,</italic>
###xml 916 922 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQL,</italic>
###xml 935 939 899 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN,</italic>
###xml 958 961 922 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
###xml 997 999 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1000 1002 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1003 1005 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1006 1008 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1009 1011 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1228 1229 1192 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The (A)9 microsatellite located at position 1610-1618 of BLM cDNA sequence was analyzed for all paired samples. Briefly, the microsatellite was amplified by PCR using 50 ng of template DNA, 1 muM of each primer, 1.5 mM of MgC12, 50 muM each of dATP, dGTP, and dTTP and 5.0 muM of dCTP, 0.1 unit of Taq DNA polymerase, and 1 muCi [alpha33P]dCTP in 10 mul of reaction volume. PCR reactions were carried out for one cycle of 94degreesC for 5 min followed by 35 cycles of 94degreesC for 30 s, 60degreesC for 30 s and 72degreesC for 30 s. PCR products from tumor and corresponding control DNAs were loaded on parallel on 6% acrylamide sequencing gels and exposed for visualization by autoradiography on Kodak X-AR films. Detection of mutations in microsatellites located in the CDRs from eight other genes (the (A)10 in TGFbeta1-RII, the (G)8 in IGFIIR, the (G)8 in BAX, the (A)8 in hMSH3, the (C)8 in hMSH6, the (A)9 in RecQL, the (A)8 in WRN, and the (ATG)6 in CBL) was done as previously described [14,16,17,24,32]. For verification, each PCR was repeated at least twice. A mutated allele was represented by a band shift of 1 to 3 bp from the normal band with intensity comparable or greater than that of the wild-type band (Fig. 1).
###end p 38
###begin title 39
Sequencing of abnormal products
###end title 39
###begin p 40
Genomic DNA fragments exhibiting band shifts were reamplified under the same conditions except for the omission of labeled dCTP. Before sequencing, the PCR products were purified either directly or after separation in a 2% agarose gel, using Qiagen purification kits. Both DNA strands were sequenced using PCR primers and an automated Applied Biosystem 377 sequencing station. Nucleotide sequences were analyzed using the Wisconsin (GCG) program package version Unix-8.1.
###end p 40
###begin title 41
Statistical analysis
###end title 41
###begin p 42
###xml 63 64 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 96 97 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The statistical analysis of results was performed using the Chi2 test or Fisher's exact test. A P value of <0.05 was considered statistically significant.
###end p 42
###begin title 43
Acknowledgement
###end title 43
###begin p 44
This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and partly from the EC BIOMED contract BMH4-CT95-0914. GC was supported by an IARC Research Training Fellowship.
###end p 44
###begin article-title 45
Molecular themes in oncogenesis.
###end article-title 45
###begin article-title 46
###xml 30 35 <span type="species:ncbi:9606">human</span>
Microsatellite instability in human solid tumors.
###end article-title 46
###begin article-title 47
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
###end article-title 47
###begin article-title 48
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
###end article-title 48
###begin article-title 49
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
###end article-title 49
###begin article-title 50
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH6</italic>
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.
###end article-title 50
###begin article-title 51
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.
###end article-title 51
###begin article-title 52
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mutL</italic>
Mutation of a mutL homolog in hereditary colon cancer.
###end article-title 52
###begin article-title 53
Lessons from hereditary colorectal cancer.
###end article-title 53
###begin article-title 54
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability.
###end article-title 54
###begin article-title 55
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
###end article-title 55
###begin article-title 56
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMLH1</italic>
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
###end article-title 56
###begin article-title 57
###xml 88 93 <span type="species:ncbi:9606">human</span>
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.
###end article-title 57
###begin article-title 58
Frameshift mutator mutations.
###end article-title 58
###begin article-title 59
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.
###end article-title 59
###begin article-title 60
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BAX</italic>
Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.
###end article-title 60
###begin article-title 61
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours.
###end article-title 61
###begin article-title 62
###xml 58 63 <span type="species:ncbi:9606">human</span>
Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.
###end article-title 62
###begin article-title 63
Transforming growth factor beta and cell cycle regulation.
###end article-title 63
###begin article-title 64
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.
###end article-title 64
###begin article-title 65
Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality.
###end article-title 65
###begin article-title 66
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
Bax suppresses tumorigenesis and stimulates apoptosis in vivo.
###end article-title 66
###begin article-title 67
Mismatch repair in replication fidelity, genetic recombination, and cancer biology.
###end article-title 67
###begin article-title 68
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBL</italic>
The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors.
###end article-title 68
###begin article-title 69
Bloom syndrome.
###end article-title 69
###begin article-title 70
Marked differences in the frequency of microsatellite instability in gastric cancer from different countries.
###end article-title 70
###begin article-title 71
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 52 63 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;RII</italic>
Microsatellite instability and mutations of p53 and TGF-betaRII genes in gastric cancer.
###end article-title 71
###begin article-title 72
The two histological main types of gastric adenocarcinomas: diffuse and so-called intestinal-type carcinoma.
###end article-title 72
###begin article-title 73
TNM classification of malignant tumours,
###end article-title 73
###begin article-title 74
Molecular cloning: A laboratory manual.
###end article-title 74
###begin article-title 75
BAT26, an indicator of the replication error phenotype in colorectal cancers and cell lines.
###end article-title 75
###begin article-title 76
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.
###end article-title 76
###begin article-title 77
The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes".
###end article-title 77
###begin article-title 78
Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis.
###end article-title 78
###begin article-title 79
Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer.
###end article-title 79
###begin article-title 80
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 74 90 <span type="species:ncbi:562">Escherichia coli</span>
Cloning and characterization of RECQL, a potential human homologue of the Escherichia coli DNA helicase RecQ.
###end article-title 80
###begin article-title 81
Positional cloning of the Werner's syndrome gene.
###end article-title 81
###begin article-title 82
The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.
###end article-title 82
###begin article-title 83
A rearrangement of the c-cbl proto-oncogene in HUT78 T-lymphoma cells results in a truncated protein.
###end article-title 83
###begin article-title 84
Defects in replication fidelity of simple repeated sequences reveal a new mutator mechanism for oncogenesis.
###end article-title 84
###begin article-title 85
Microsatellite instability: the mutator that mutates the other mutator.
###end article-title 85
###begin article-title 86
###xml 35 40 <span type="species:ncbi:9606">human</span>
Evidence of genetic progression in human gastric carcinomas with microsatellite instability.
###end article-title 86
###begin article-title 87
###xml 140 178 140 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;RII, BAX, HMSH3, HMSH6, IGFIIR</italic>
###xml 183 186 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-patological parameters: a study of the TGF-betaRII, BAX, HMSH3, HMSH6, IGFIIR and BLM genes.
###end article-title 87
###begin article-title 88
Bloom's syndrome XVIII. Hypermutability at a tandem-repeat locus.
###end article-title 88
###begin article-title 89
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.
###end article-title 89
###begin article-title 90
The Bloom's syndrome gene product is a 3'-5' DNA helicase.
###end article-title 90
###begin article-title 91
###xml 0 13 <span type="species:ncbi:4896">Fission yeast</span>
Fission yeast rad12+ regulates cell cycle checkpoint control and is homologous to the Bloom's syndrome disease gene.
###end article-title 91
###begin article-title 92
###xml 9 22 <span type="species:ncbi:4896">fission yeast</span>
rqh1+, a fission yeast gene related to the Bloom's and Werner's syndrome genes, is required for reversible S phase arrest.
###end article-title 92
###begin article-title 93
###xml 10 34 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
SGS1, the Saccharomyces cerevisiae homologue of BLm and WRN, suppresses genome instability and homeologous recombination.
###end article-title 93
###begin article-title 94
###xml 74 79 <span type="species:ncbi:9606">human</span>
Mutation of HMSH3 and HMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas.
###end article-title 94
###begin article-title 95
Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype.
###end article-title 95
###begin article-title 96
Mutations at coding mononucleotide repeats in gastric cancer with the microsatellite mutator phenotype.
###end article-title 96

